Medicine and Dentistry
Multiple Sclerosis
57%
Randomized Controlled Trial
47%
Low Fat Diet
42%
Tertiary Care
42%
Tumor Necrosis Factor
42%
Clinically Isolated Syndrome
42%
TNF Inhibitor
42%
Epileptic Seizure
42%
Fatigue Impact Scale
31%
Diet Therapy
21%
Scalp
17%
Intention-to-Treat Analysis
10%
Symptom
10%
Drug Therapy
10%
Caloric Intake
10%
Counseling
10%
Anesthetic Agent
10%
Food Frequency Questionnaire
10%
Anticonvulsant
7%
Neuroinflammation
5%
Agents Acting on the Eye
5%
Magnetic Resonance Imaging
5%
Clinical Trial
5%
Experimental Autoimmune Encephalomyelitis
5%
Neutralization
5%
Myelin
5%
Infliximab
5%
Demyelination
5%
Drug Megadose
5%
Remyelination
5%
Inflammatory Disorder
5%
Dermatological Agent
5%
Disease
5%
Nervous System
5%
Adverse Event
5%
Demyelinating Disorder
5%
Keyphrases
Low-fat Diet
42%
Randomized Controlled Trial
42%
Multiple Sclerosis
42%
Implantation Effect
42%
Intracranial EEG Monitoring
33%
Confidence Interval
31%
Modified Fatigue Impact Scale
31%
Active Groups
21%
24-hour Dietary Recall
21%
Dietary Intervention
21%
Daily Caloric Intake
10%
Intent-to-treat
10%
Effective Treatment
10%
Sensitivity Analysis
10%
Scale Difference
10%
Nutrition Counseling
10%
Treatment Options
10%
Wait-list Control
10%
Food Frequency Questionnaire
10%
Calories
10%
Low Fat
10%
Intracranial Implants
8%
Post-marketing Monitoring
6%
Neuroscience
Multiple Sclerosis
100%
Randomized Controlled Trial
47%
Necrosis
42%
Vascular Disease
42%
TNF Inhibitor
42%
Demyelinating Disease
42%
Metabolic Pathway
42%
Dietary Fat
14%
Intention
14%
Adenosine Triphosphate
9%
High Energy Phosphate
7%
Myelin
5%
Nervous System
5%
Experimental Autoimmune Encephalomyelitis
5%
Remyelinization
5%
Infliximab
5%
Demyelinating Disorder
5%
Magnetic Resonance Imaging
5%
Adverse Effect
5%
